临床研究

手术干预对卵巢型子宫内膜异位症患者IVF/ICSI助孕结局的影响

  • 刘文霞 ,
  • 罗如思 ,
  • 梁芳芳 ,
  • 王晓丹 ,
  • 管一春
展开
  • 郑州大学第三附属医院生殖医学科 (河南 郑州 450052 )

收稿日期: 2025-01-24

  网络出版日期: 2025-07-29

基金资助

国家重点研发计划(2022YFC2703500)

Effect of surgical intervention on IVF/ICSI outcomes in patients with ovarian endometriosis

  • Wenxia LIU ,
  • Rusi LUO ,
  • Fangfang LIANG ,
  • Xiaodan WANG ,
  • Yichun. GUAN
Expand
  • Center for Reproductive Medicine,the Third Affliated Hospital of Zhengzhou University,Zhengzhou 450052,Henan,China

Received date: 2025-01-24

  Online published: 2025-07-29

摘要

目的 探讨手术干预对卵巢型子宫内膜异位症(ovarian endometriosis,OEM)患者IVF/ICSI助孕结局的影响。 方法 选取2019年1月1日至2024年2月1日期间于郑州大学第三附属医院生殖中心行IVF/ICSI治疗的OEM患者,其中助孕前未手术组228例(A组)、助孕前手术组426例(B组),分析两组的助孕结局。 结果 两组间的女方年龄、BMI、不孕年限、不孕类型、基础FSH水平、AFC均差异无统计学意义(P > 0.05)。B组的AMH水平低于A组(P = 0.003)。两组间促排卵方案的应用、Gn总天数、Gn总量均差异无统计学意义(P > 0.05),但B组的Gn启动量高于A组(P = 0.011)。运用多重线性回归调整混杂因素后,A组和B组间的2PN受精率差异有统计学意义(P = 0.007),而两组间的获卵数、可利用胚胎率、优质胚胎率、囊胚形成率均差异无统计学意义(P > 0.05)。应用二元logistic回归对临床妊娠率、活产率相关影响因素进行调整后,两组的临床妊娠率(aOR = -0.896,95%CI: 0.540 ~ 1.488)、活产率(aOR = 0.976,95%CI: 0.589 ~ 1.620)仍然差异无统计学意义。 结论 手术干预可能会进一步损伤OEM患者的卵巢储备功能,但似乎并不影响胚胎质量及妊娠结局。助孕前手术治疗可能会改善OEM患者的受精率。

本文引用格式

刘文霞 , 罗如思 , 梁芳芳 , 王晓丹 , 管一春 . 手术干预对卵巢型子宫内膜异位症患者IVF/ICSI助孕结局的影响[J]. 实用医学杂志, 2025 , 41(14) : 2204 -2209 . DOI: 10.3969/j.issn.1006-5725.2025.14.012

Abstract

Objective To investigate the effect of surgical intervention on IVF/ICSI assisted conception outcomes in patients with ovarian endometriosis (OEM). Methods OEM patients who underwent IVF/ICSI treatment at the Reproductive Center of the Third Affiliated Hospital of Zhengzhou University between January 1, 2019 and February 1, 2024 were selected, including 228 cases in the non-operated group before assisted conception (Group A) and 426 cases in the operated group before assisted conception (Group B), and the assisted conception outcomes of the two groups were analysed. Results There were no statistically significant differences in female age, BMI, infertility years, infertility type, and basal FSH level between the two groups (P > 0.05). AMH level and basal AFC were higher in group A than in group B (P = 0.003). There was no statistical difference in the application of ovulation induction programme, total number of Gn days and total amount of Gn between the two groups (P > 0.05), but the amount of Gn initiation in Group A was lower than that in Group B (P = 0.011). Applying multiple linear regression to adjust for confounding factors, there was a statistical difference in the 2PN fertilization rate between Groups A and B (P = 0.007), whereas there was no statistical difference in the number of eggs obtained, the rate of available embryos, the rate of high-quality embryos and the rate of blastocyst formation between the two groups (P > 0.05). After applying binary logistic regression to adjust for the influencing factors related to clinical pregnancy rate and live birth rate, the clinical pregnancy rate (aOR = -0.896, 95%CI: 0.540 ~ 1.488), live birth rate in the two groups (aOR = 0.976, 95%CI: 0.589 ~ 1.620) remained statistically indistinguishable. Conclusions Surgical intervention may further impair ovarian reserve function in patients with OEM, but does not appear to affect embryo quality or pregnancy outcome. Surgical treatment prior to assisted conception may improve fertilization rates in patients with OEM.

参考文献

[1] 中国医师协会妇产科医师分会, 中华医学会妇产科学分会子宫内膜异位症协作组. 子宫内膜异位症诊治指南(第三版) [J]. 中华妇产科杂志, 2021, 56(12): 812-824.
[2] 黄薇, 冷金花, 裴天骄, 等. 子宫内膜异位症患者生育力保护的中国专家共识(2022版) [J]. 中华妇产科杂志, 2022, 57(10): 733-739.
[3] BECKER C M, BOKOR A, HEIKINHEIMO O, et al. ESHRE guideline: Endometriosis [J]. Hum Reprod Open, 2022, 2022(2): hoac009. doi:10.1093/hropen/hoac009
[4] HODGSON R M, LEE H L, WANG R, et al. Interventions for endometriosis-related infertility: A systematic review and network meta-analysis [J]. Fertil Steril, 2020, 113(2): 374-382.e372. doi:10.1016/j.fertnstert.2019.09.031
[5] BAFORT C, BEEBEEJAUN Y, TOMASSETTI C, et al. Laparoscopic surgery for endometriosis [J]. Cochrane Database Syst Rev, 2020, 10(10): CD011031. doi:10.1002/14651858.cd011031.pub3
[6] WU Y, YANG R, LAN J, et al. Ovarian Endometrioma Negatively Impacts Oocyte Quality and Quantity But Not Pregnancy Outcomes in Women Undergoing IVF/ICSI Treatment: A Retrospective Cohort Study [J]. Front Endocrinol(Lausanne), 2021, 12: 739228. doi:10.3389/fendo.2021.739228
[7] DONGYE H, TIAN Y, QI D, et al. The Impact of Endometrioma on Embryo Quality in In Vitro Fertilization: A Retrospective Cohort Study [J]. J Clin Med, 2023, 12(6):2416. doi:10.3390/jcm12062416
[8] YOUNIS J S, TAYLOR H S. The impact of ovarian endometrioma and endometriotic cystectomy on anti-Müllerian hormone, and antral follicle count: A contemporary critical appraisal of systematic reviews [J]. Front Endocrinol (Lausanne), 2024, 15: 1397279. doi:10.3389/fendo.2024.1397279
[9] DEMIRDAG E, GULER I, SELVI I, et al. Analysis of 2438 cycles for the impact of endometrioma and its surgery on the IVF outcomes [J]. Eur J Obstet Gynecol Reprod Biol, 2021, 263: 233-238. doi:10.1016/j.ejogrb.2021.06.034
[10] 李文静, 管一春, 于爽, 等. 体脂率对不孕症女性IVF/ICSI妊娠结局的影响 [J]. 中华生殖与避孕杂志, 2024, 44(12): 1250-1257.
[11] GARRIDO N, NAVARRO J, REMOHí J, et al. Follicular hormonal environment and embryo quality in women with endometriosis [J]. Hum Reprod Update, 2000, 6(1): 67-74. doi:10.1093/humupd/6.1.67
[12] FERRERO H, CORACHáN A, AGUILAR A, et al. Single-cell RNA sequencing of oocytes from ovarian endometriosis patients reveals a differential transcriptomic profile associated with lower quality [J]. Hum Reprod, 2019, 34(7): 1302-1312. doi:10.1093/humrep/dez053
[13] YILMAZ N, CERAN M U, UGURLU E N, et al. Impact of endometrioma and bilaterality on IVF/ICSI cycles in patients with endometriosis [J]. J Gynecol Obstet Hum Reprod, 2021, 50(3): 101839. doi:10.1016/j.jogoh.2020.101839
[14] KASAPOGLU I, ATA B, UYANIKLAR O, et al. Endometrioma-related reduction in ovarian reserve (ERROR): A prospective longitudinal study [J]. Fertil Steril, 2018, 110(1): 122-127. doi:10.1016/j.fertnstert.2018.03.015
[15] PARK W, LIM W, KIM M, et al. Female reproductive disease, endometriosis: From inflammation to infertility [J]. Mol Cells, 2025, 48(1): 100164. doi:10.1016/j.mocell.2024.100164
[16] TRAN D N, HWANG Y J, KIM K C, et al. GRB2 regulation of essential signaling pathways in the endometrium is critical for implantation and decidualization [J]. Nat Commun, 2025, 16(1): 2192. doi:10.1038/s41467-025-57173-2
[17] DANIILIDIS A, GRIGORIADIS G, KALAITZOPOULOS D R, et al. Surgical Management of Ovarian Endometrioma: Impact on Ovarian Reserve Parameters and Reproductive Outcomes [J]. J Clin Med, 2023, 12(16):5324. doi:10.3390/jcm12165324
[18] DIAS J A Jr, IZZO C R, FASSOLAS G, et al. The endometrioma paradox [J]. JBRA Assist Reprod, 2025, 29(1): 145-149.
[19] ALAMMARI R, LIGHTFOOT M, HUR H C. Impact of Cystectomy on Ovarian Reserve: Review of the Literature [J]. J Minim Invasive Gynecol, 2017, 24(2): 247-257. doi:10.1016/j.jmig.2016.12.010
[20] SUN X, XIONG W, LIU L, et al. Comparison of the predictive capability of antral follicle count vs. the anti-Müllerian hormone for ovarian response in infertile women [J]. Front Endocrinol (Lausanne), 2022, 13: 862733. doi:10.3389/fendo.2022.862733
[21] OLIVEIRA T F S, BARREIRO M, TOMé A, et al. Female Reproductive Health-Study of an egg donor population [J]. JBRA Assist Reprod, 2023, 27(4): 638-643.
[22] REIS A B, LEAL C, BARREIRO M, et al. Anti-Müllerian hormone as a predictor of the number of oocytes obtained during in vitro fertilization treatments [J]. JBRA Assist Reprod, 2024, 28(4): 597-603.
[23] 汤小晗, 唐淑丽, 王明磊, 等. 子宫内膜异位症相关性不孕症患者的胚胎质量及IVF/ICSI-ET结局的研究 [J]. 中华生殖与避孕杂志, 2024, 44(8): 791-797.
[24] HERNáNDEZ A, SANZ A, SPAGNOLO E, et al. Impact of Ovarian Endometrioma and Surgery on Reproductive Outcomes: A Single-Center Spanish Cohort Study [J]. Biomedicines, 2023, 11(3):844. doi:10.3390/biomedicines11030844
[25] 陈曼, 林虹, 王玉莲, 等. 子宫内膜异位症相关不孕患者体外受精/卵胞浆内单精子注射助孕方案的比较 [J]. 实用医学杂志, 2020, 36(17): 2415-2419.
[26] 郭钰英, 赵晓丹, 戴芳芳, 等. 高孕激素下促排卵方案在子宫内膜异位症卵巢储备功能降低患者中的应用分析 [J]. 生殖医学杂志, 2022, 31(1): 45-51.
文章导航

/